Loading clinical trials...
Loading clinical trials...
Major depressive disorder (MDD) is a chronic mental illness, with 60% lifetime risk of recurrence after the first MDD episode. Despite available treatment options for MDD, only about half to two-third...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Lithuanian University of Health Sciences
NCT07088380 · Major Depressive Disorder, Treatment Resistant Depression
NCT06843187 · Major Depressive Disorder(MDD), Insomnia Comorbid to Psychiatric Disorder
NCT06564818 · Major Depressive Disorder
NCT07011394 · Diagnosis, Inflammation, and more
NCT07571473 · Surgical Stress Response, Inflammation, and more
Psychiatry Department, Hospital of Lithuanian University of Health Sciences Kaunas Clinics
Kaunas
Psychiatry Department, Hospital of Lithuanian University of Health Sciences Kaunas Clinics
Kaunas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions